Prospective Randomized Open Blinded End-point (PROBE) Study. A novel design for intervention trials
- 1 January 1992
- journal article
- research article
- Published by Taylor & Francis in Blood Pressure
- Vol. 1 (2) , 113-119
- https://doi.org/10.3109/08037059209077502
Abstract
A novel design for intervention studies is presented, the so called PROBE study (Prospective Randomized Open, Blinded End-point). This design is compared to the classical double-blind design. Among the advantages of the PROBE design are lower cost and greater similarity to standard clinical practice, which should make the results more easily applicable in routine medical care. Since end-points are evaluated by a blinded end-point committee it is obvious that there should be no difference between the two types of trials in this regard.Keywords
This publication has 33 references indexed in Scilit:
- A Utilitarian or Deontological Approach Toward Primary Prevention of Cardiovascular Disease?Acta Medica Scandinavica, 2009
- Medical Research Council trial of treatment of hypertension in older adults: principal results. MRC Working Party.BMJ, 1992
- Morbidity and mortality in the Swedish Trial in Old Patients with Hypertension (STOP-Hypertension)The Lancet, 1991
- Studies of Left Ventricular Dysfunction (SOLVD)—Rationale, design and methods: Two trials that evaluate the effect of enalapril in patients with reduced ejection fractionThe American Journal of Cardiology, 1990
- Future Directions for Randomized Trials of Cardiovascular Disease Prevention in Hypertensive PatientsJournal of Cardiovascular Pharmacology, 1990
- STOP-Hypertension: Swedish Trial in Old Patients with HypertensionJournal Of Hypertension, 1986
- The Lipid Research Clinics Coronary Primary Prevention Trial ResultsJAMA, 1984
- Heart Study Produces a Surprise ResultScience, 1982
- Multiple Risk Factor Intervention TrialJAMA, 1982
- The Effectiveness of Long-Term Treatment of Malignant HypertensionCirculation, 1958